• 12401 Citations
  • 37 h-Index
1977 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Daniel D Karp is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Lung Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
docetaxel Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Survival Medicine & Life Sciences
Clinical Trials, Phase I Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1977 2019

Open Access
Internet
Observational Studies
Decision Making
Cross-Sectional Studies
Physicians

Phase 1 study of the combination of vemurafenib, carboplatin, and paclitaxel in patients with BRAF-mutated melanoma and other advanced malignancies

Bhatty, M., Kato, S., Piha-Paul, S. A., Naing, A., Subbiah, V., Huang, H. J., Karp, D. D., Tsimberidou, A. M., Zinner, R. G., Hwu, W-J., Javle, M., Patel, S. P., Hu, M. I-N., Varadhachary, G. R., Conley, A. P., Ramzanali, N. M., Holley, V. R., Kurzrock, R., Meric-Bernstam, F., Kwang Chae, Y. & 3 others, Kim, K. B., Falchook, G. S. & Janku, F., Feb 1 2019, In : Cancer. 125, 3, p. 463-472 10 p.

Research output: Contribution to journalArticle

Carboplatin
Paclitaxel
Melanoma
Mitogen-Activated Protein Kinase Kinases
Neoplasms
5 Citations (Scopus)
Triple Negative Breast Neoplasms
Breast Neoplasms
Therapeutics
Disease-Free Survival
Phosphatidylinositol 3-Kinases